Loading…
Product type
Ponatinib Hydrochloride is a potent tyrosine kinase inhibitor primarily used in the treatment of certain types of leukemia, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by blocking the activity of specific enzymes involved in the growth and spread of cancer cells. This active pharmaceutical ingredient (API) is typically synthesized through complex chemical processes to ensure its efficacy and safety for medicinal use.
| Chemical formula | C24H26ClN5O2 |
| Molecular weight | 435.95 g/mol |
| Purity | ≥ 98% |
| Form | Powder |
| Solubility | Soluble in DMSO and methanol |
When selecting Ponatinib Hydrochloride, buyers should consider the required purity levels and the form of the API. It is important to specify the intended use, whether for research, clinical trials, or commercial production. Additionally, inquire about the supplier's certifications, such as Good Manufacturing Practices (GMP), and ensure they can provide documentation for batch consistency and quality control.
Get quotes for Ponatinib Hydrochloride
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia.
It is typically administered orally in tablet form.
It should be stored in a cool, dry place away from light.
No, it is not suitable for all patients; a healthcare provider should assess individual risks.
Common side effects include fatigue, rash, and potential cardiovascular issues.
Yes, but it should be done under medical supervision due to potential interactions.